In this correspondence, we briefly explain how details on cardio-ankle vascular index (CAVI; \[[@R1]\]) as recently released by Fukuda Denshi \[[@R2]\] can be used to convert CAVI into CAVI~0~\[[@R3]\]. We provide an easy-to-use PDF calculator as well as a Microsoft Excel workbook to facilitate this process (Supplemental digital content 1 and 2).

We have recently investigated the theoretical blood pressure dependence of cardio-ankle vascular index as measured using the VaSera device (Fukuda Denshi Co., Ltd., Tokyo, Japan) and proposed a novel, corrected index: CAVI~0~\[[@R3]\]. Direct conversion between CAVI and CAVI~0~ proved difficult, as the CAVI equation contains two proprietary scale coefficients *a* and *b*\[[@R1]\]: 

with PWV the pulse wave velocity from the heart to the left or right ankle (resulting in L-CAVI or R-CAVI, respectively), *P*~s~ and *P*~d~ the SBP and DBP as measured by the VaSera device at the right upper arm (regardless of computing L-CAVI or R-CAVI \[[@R2],[@R4]\]), and ![](jhype-37-1913-i001.jpg) the blood mass density \[[@R2]\].

We previously set out to estimate scale coefficients *a* and *b* from measurement data \[[@R4]\]. Such method, however, necessarily has the limitation that *a* and *b* can only be obtained approximately and not exactly. Recently, Fukuda Denshi fully disclosed the values of *a* and *b*, as well as other details on the calculation of CAVI \[[@R2]\] -- a step that should be applauded. This disclosure allows for a direct, exact conversion of CAVI into CAVI~0~: 

with *P*~ref~ = 100 mmHg a reference pressure \[[@R3]\]. The values of *a* and *b* in the CAVI equation are different for different ranges of CAVI \[[@R2]\]. Two cut-off points are implemented, resulting in three sets of values for the coefficients *a* and *b*. Figure [1](#F1){ref-type="fig"} visualizes these variable scaling coefficients, as well as the cut-off points in CAVI and unscaled CAVI. This also implies that, when converting CAVI to CAVI~0~ (Eq. 2), the values for *a* and *b* should be matched to the measured value of CAVI.

![Influence of the use of three sets of scale coefficients *a* and *b*\[[@R2]\] on the relationship (*y* = *ax* + *b*) between cardio-ankle vascular index (CAVI, *y*) and unscaled CAVI (*x*).](jhype-37-1913-g003){#F1}

To simplify the CAVI-to-CAVI~0~ conversion process, we created an easily fillable Adobe PDF form for conversion of single CAVI measurements (Fig. [2](#F2){ref-type="fig"}, Supplemental digital content 1) as well as a Microsoft Excel workbook for conversion of larger data sets (Supplemental digital content 2). Note that the PDF form was designed to be opened using Adobe Reader (<http://www.adobe.com/go/getreader>); other PDF readers may not support in-PDF calculations.

![Screenshot of Adobe PDF CAVI-to-CAVI~0~ conversion tool with a completed CAVI-to-CAVI~0~ conversion (Supplemental digital content 1). The user enters CAVI and SBP and DBP values (*P*~s~ and *P*~d~) in the light boxes, after which the form automatically determines the appropriate scale coefficients (*a* and *b*), determines unscaled CAVIs, and converts those to CAVI~0~s. CAVI, cardio-ankle vascular index; CAVI~0~, cardio-ankle vascular index zero \[[@R3]\]; *P*~ref~, reference pressure \[[@R3]\].](jhype-37-1913-g004){#F2}

The critical reader is pointed to some nomenclature variations: in this correspondence, CAVI as provided by the VaSera device is simply termed CAVI; our previous studies referred to it as CAVI~VS~\[[@R3],[@R4]\]. Unscaled CAVI (this correspondence) is called haβ by Takahashi *et al.*\[[@R2]\] and was referred to simply as CAVI in our previous studies \[[@R3],[@R4]\]. Finally, we would like to point out that a researcher with full access to the CAVI (VaSera) source data can also compute CAVI~0~ (Eqs. 9 and 10 in \[[@R4]\]) without CAVI as an intermediate step.

In conclusion, we hope that this correspondence and the tools provided will help every user interested in using CAVI~0~ -- whether clinician, researcher, or engineer -- to easily convert CAVI into CAVI~0~ values.
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